Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response

Lignende værker

• Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response
  af: Andre De Souza, et al.
  Udgivet: (2020-10-01)
• Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition
  af: Josh T. Coats, et al.
  Udgivet: (2023-06-01)
• GSK-3 protein and the heart: friend or foe?
  af: B. Huisamen, et al.
  Udgivet: (2017-04-01)
• GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer
  af: Octavio Silva-García, et al.
  Udgivet: (2020-12-01)
• Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro
  af: Selvi Kunnimalaiyaan, et al.
  Udgivet: (2018-05-01)